TABLE 2.
Measures of child development by preschool quality, in preschoolers administered MNP or placebo from baseline to endline (8 mo)1
Time effects (P values) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High-quality preschools | Effect size | Low-quality preschools | Effect size | Baseline preschool | Endline × | Endline × | Endline × MNP × | |||||||
∆2 | n | MNP | Placebo | P 3 | (95% CI) | MNP | Placebo | P 3 | (95% CI)4 | quality | MNP | quality | quality | |
Expressive language score5 | BL | 321 | 41.6 ± 1.2 | 40.1 ± 1.4 | 0.34 | 38.2 ± 1.3 | 36.8 ± 1.3 | 0.34 | 0.02 | |||||
EL | 293 | 40.5 ± 1.4 | 40.8 ± 1.6 | 0.89 | 40.2 ± 1.5 | 34.4 ± 1.4 | 0.003 | 0.02 | 0.11 | 0.01 | ||||
∆ | –1.0 ± 1.2 | 0.6 ± 1.5 | 0.36 | –0.2 (–0.6, 0.2) | 2.0 ± 1.4 | –2.3 ± 1.2 | 0.02 | 0.4 (0.1, 0.8) | ||||||
Receptive language score5 | BL | 321 | 43.7 ± 0.8 | 43.0 ± 0.9 | 0.52 | 41.5 ± 0.9 | 40.8 ± 0.8 | 0.52 | 0.03 | |||||
EL | 293 | 37.4 ± 0.9 | 37.0 ± 1.1 | 0.74 | 34.5 ± 1.0 | 35.3 ± 0.9 | 0.57 | 0.28 | 0.70 | 0.49 | ||||
∆ | –6.2 ± 0.9*** | –6.1 ± 1.0*** | 0.88 | 0.0 (−0.4, 0.4) | –6.9 ± 1.0*** | –5.5 ± 0.9*** | 0.28 | –0.2 (–0.5, 0.2) | ||||||
Fine motor score4 | BL | 321 | 46.5 ± 1.4 | 46.5 ± 1.5 | 1.00 | 44.1 ± 1.5 | 44.1 ± 1.4 | 1.00 | 0.15 | |||||
EL | 293 | 47.8 ± 1.5 | 46.5 ± 1.5 | 0.81 | 44.5 ± 1.6 | 44.2 ± 1.5 | 0.90 | 0.89 | 0.73 | 0.92 | ||||
∆ | 47.3 ± 1.7 | 0.79 | 0.0 (–0.3, 0.3) | 0.4 ± 1.4 | 0.1 ± 1.3 | 0.89 | 0.0 (–0.3, 0.3) | |||||||
Visual reception score5 | BL | 321 | 43.9 ± 1.2 | 42.3 ± 1.4 | 0.27 | 42.3 ± 1.3 | 40.6 ± 1.3 | 0.27 | 0.27 | |||||
EL | 293 | 42.7 ± 1.3 | 42.7 ± 1.6 | 1.00 | 41.0 ± 1.5 | 40.0 ± 1.4 | 0.57 | 0.74 | 0.52 | 0.64 | ||||
∆ | –1.2 ± 1.1 | 0.5 ± 1.4 | 0.34 | –0.2 (–0.5, 0.2) | –1.2 ± 1.3 | –0.7 ± 1.2 | 0.74 | –0.1 (–0.4, 0.3) | ||||||
Inhibitory control score6 | BL | 319 | 2.8 ± 0.4 | 2.3 ± 0.4 | 0.36 | 2.6 ± 0.4 | 2.2 ± 0.4 | 0.36 | 0.73 | |||||
EL | 293 | 4.3 ± 0.4 | 5.0 ± 0.5 | 0.26 | 4.4 ± 0.5 | 3.0 ± 0.4 | 0.02 | 0.07 | 0.001 | 0.004 | ||||
∆ | 1.5 ± 0.4*** | 2.7 ± 0.4*** | 0.04 | –0.3 (–0.7, 0.0) | 1.8 ± 0.4*** | 0.8 ± 0.4* | 0.07 | 0.2 (–0.1, 0.6) | ||||||
Social–emotional development score6 | BL | 321 | 24.7 ± 0.4 | 24.1 ± 0.4 | 0.19 | 23.8 ± 0.4 | 23.2 ± 0.4 | 0.19 | 0.07 | |||||
EL | 293 | 22.8 ± 0.5 | 23.3 ± 0.6 | 0.47 | 23.3 ± 0.5 | 21.9 ± 0.5 | 0.03 | 0.26 | 0.48 | 0.04 | ||||
∆ | –1.9 ± 0.5** | –0.8 ± 0.6 | 0.13 | –0.3 (–0.8, 0.1) | –0.5 ± 0.6 | –1.3 ± 0.5* | 0.26 | 0.2 (–0.2, 0.6) |
Values are means ± SEs unless otherwise indicated. *P < 0.05, **P < 0.001, ***P < 0.0001. BL, baseline; EL, endline; MNP, multiple micronutrient powder.
Within-intervention group change from baseline.
P value for MNP compared with placebo difference in baseline mean, endline mean, and change from baseline.
Cohen's d for the difference in change scores from baseline to endline comparing MNP with placebo. Conventions: small = 0.2, medium = 0.5, large = 0.8 (38).
Mean T scores ± SEs, age-standardized.
Raw score, adjusted for mean-centered age.